FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessment and Decision Support in High-Risk Women
This clinical trial tests the impact of Fast Healthcare Interoperability Resources (FHIR)-enhanced RealRisks on the accuracy of breast cancer risk assessment and decision support in women at high-risk for breast cancer. Women identified as high-risk for breast cancer may benefit from personalized risk-reducing strategies. However, barriers exist for women to obtain these risk-reducing strategies including the time required to conduct risk assessment for each woman. Electronic health records (EHRs), a common source for populating risk assessment models present challenges, including missing data, as well as data type. Data may be more accurate when provided by patients compared to EHRs. RealRisks, a decision aid, assists in women's understanding of breast cancer risk and uses patient-entered data to calculate risk. FHIR-enhanced RealRisks uses both patient-generated health data and EHR data to populate information for breast cancer risk, maximizing the strengths of both types of data. FHIR-enhanced RealRisks may improve the accuracy of breast cancer risk assessment and decision support in women at high-risk for breast cancer.